1. Home
  2. KALU vs HAE Comparison

KALU vs HAE Comparison

Compare KALU & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kaiser Aluminum Corporation

KALU

Kaiser Aluminum Corporation

HOLD

Current Price

$187.17

Market Cap

3.0B

Sector

Industrials

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$77.29

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KALU
HAE
Founded
1946
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.8B
IPO Year
2006
1996

Fundamental Metrics

Financial Performance
Metric
KALU
HAE
Price
$187.17
$77.29
Analyst Decision
Hold
Buy
Analyst Count
3
9
Target Price
$147.33
$84.13
AVG Volume (30 Days)
216.8K
991.1K
Earning Date
04-22-2026
05-07-2026
Dividend Yield
1.78%
N/A
EPS Growth
135.89
N/A
EPS
3.71
2.05
Revenue
$1,585,900,000.00
$910,373,000.00
Revenue This Year
$13.37
N/A
Revenue Next Year
$2.62
$5.23
P/E Ratio
$48.98
$37.86
Revenue Growth
N/A
N/A
52 Week Low
$71.44
$47.32
52 Week High
$195.22
$87.32

Technical Indicators

Market Signals
Indicator
KALU
HAE
Relative Strength Index (RSI) 52.97 66.34
Support Level $172.51 $48.98
Resistance Level $194.82 $81.99
Average True Range (ATR) 8.14 3.47
MACD -1.06 -0.33
Stochastic Oscillator 48.03 61.76

Price Performance

Historical Comparison
KALU
HAE

About KALU Kaiser Aluminum Corporation

Kaiser Aluminum Corp specializes in the production of semi-fabricated specialty aluminum mill products, such as aluminum plate and sheet, bare and coated coil and extruded and drawn products, for the end market applications: Aero/HS Products; Packaging; GE Products; and Automotive Extrusions. Its products include fabricated aluminum mill products such as flat-rolled (plate, sheet, and coil), extruded (rod, bar, hollows, and shapes), drawn (rod, bar, pipe, tube and wire) and certain cast aluminum products. Geographically, the company generates majority of its revenue from the United States.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: